Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : AZN source : Www.globenewswire.com save search
Fortress Biotech Reports 2023 Financial Results and Recent Corporate Highlights
Published: 2024-03-28 (Crawled : 20:00) - globenewswire.com
AZNCF | News | $140.3 -4.19% 1.5K
|
Health Technology
| Email alert
Add to watchlist
FBIO | $1.785 -1.38% -1.4% 120K
|
Health Technology
| Email alert
Add to watchlist
DERM | $3.425 -3.25% -3.36% 60K
|
| Email alert
Add to watchlist
MBIO | $0.35 -2.7% -2.77% 120K
|
Health Technology
| Email alert
Add to watchlist
AZN | News | $71.175 0.46% 0.46% 6.1M
|
Health Technology
| Email alert
Add to watchlist
CKPT | $1.44 0.35% 0.35% 180K
|
Health Technology
| Email alert
Add to watchlist
biotech financial results
Artelo Biosciences Reports Fiscal 2023 Year-End Financial Results and Provides Business Update
Published: 2024-03-25 (Crawled : 12:00) - globenewswire.com
AZNCF | News | $140.3 -4.19% 1.5K
|
Health Technology
|
| O: 0.75%
H: 0.04%
C: -0.1%
AZN | News | $71.175 0.46% 0.46% 6.1M
|
Health Technology
|
| O: -0.08%
H: 0.33%
C: -0.53%
ARTL | News | $1.31 0.0% 5.4K
|
Health Technology
|
| O: -4.61%
H: 4.83%
C: 3.84%
business update financial results
ACELYRIN, INC. Appoints Lynn Tetrault to Board of Directors
Published: 2023-12-20 (Crawled : 22:00) - globenewswire.com
SLRN | $4.57 -0.65% -0.66% 530K
|
|
| O: 0.98%
H: 0.9%
C: -0.97%
AZNCF | News | $140.3 -4.19% 1.5K
|
Health Technology
|
| O: -0.0%
H: 1.62%
C: -0.47%
RYTM 4 | $39.71 -0.73% -0.73% 400K
|
Health Technology
|
| O: 2.05%
H: 0.69%
C: -1.35%
NEO | $14.03 -0.92% -0.93% 540K
|
Health Services
|
| O: 2.39%
H: 5.33%
C: 4.31%
AZN | News | $71.175 0.46% 0.46% 6.1M
|
Health Technology
|
| O: 1.44%
H: 0.22%
C: -0.64%
Icosavax, Inc. Announces Agreement to be Acquired by AstraZeneca
Published: 2023-12-12 (Crawled : 07:00) - globenewswire.com
AZNCF | News | $140.3 -4.19% 1.5K
|
Health Technology
|
| O: 5.03%
H: 0.0%
C: -3.82%
ICVX | $15.31 -0.65% 9.3M
|
|
| O: 53.48%
H: 1.02%
C: 0.26%
AZN | News | $71.175 0.46% 0.46% 6.1M
|
Health Technology
|
| O: 1.54%
H: 0.06%
C: -0.78%
astrazeneca acquired agreement
Rakovina Therapeutics Inc. Announces Q3 2023 Financial Results and Provides Corporate Update
Published: 2023-11-28 (Crawled : 01:00) - globenewswire.com
AZNCF | News | $140.3 -4.19% 1.5K
|
Health Technology
|
| O: -2.8%
H: 0.19%
C: -0.16%
AZN | News | $71.175 0.46% 0.46% 6.1M
|
Health Technology
|
| O: -0.72%
H: 0.52%
C: 0.16%
update therapeutics financial results
Rakovina Therapeutics Announces Appointment of New Scientific Advisory Board Member
Published: 2023-11-20 (Crawled : 14:00) - globenewswire.com
AZNCF | News | $140.3 -4.19% 1.5K
|
Health Technology
|
| O: 0.04%
H: 0.0%
C: -1.49%
AZN | News | $71.175 0.46% 0.46% 6.1M
|
Health Technology
|
| O: -1.39%
H: 1.02%
C: 0.87%
therapeutics
Cellectis Announces the execution of the Subsequent Investment Agreement with AstraZeneca
Published: 2023-11-15 (Crawled : 08:00) - globenewswire.com
CLLS | News | $2.53 -3.42% -3.55% 39K
|
Health Technology
|
| O: 3.13%
H: 6.82%
C: 6.06%
AZN | News | $71.175 0.46% 0.46% 6.1M
|
Health Technology
|
| O: -1.15%
H: 0.43%
C: -0.57%
astrazeneca agreement
Artelo Biosciences Announces Publication of New Peer-Reviewed Research Demonstrating Protective Properties of ART27.13 Against Muscle Degeneration Caused by Certain Cancers
Published: 2023-11-09 (Crawled : 14:00) - globenewswire.com
AZNCF | News | $140.3 -4.19% 1.5K
|
Health Technology
|
| O: 2.33%
H: 0.83%
C: -0.88%
AZN | News | $71.175 0.46% 0.46% 6.1M
|
Health Technology
|
| O: 2.72%
H: 0.49%
C: -1.79%
ARTL | News | $1.31 0.0% 5.4K
|
Health Technology
|
| O: 3.47%
H: 0.0%
C: -11.41%
art27 art27.13 publication research
Cellectis Announces Strategic Collaboration and Investment Agreements with AstraZeneca
Published: 2023-11-01 (Crawled : 07:00) - globenewswire.com
CLLS | News | $2.53 -3.42% -3.55% 39K
|
Health Technology
|
| O: 179.38%
H: 10.33%
C: -2.58%
AZN | News | $71.175 0.46% 0.46% 6.1M
|
Health Technology
|
| O: 0.03%
H: 1.17%
C: 0.84%
collaboration
Together for CHANGE Genomics and Equity Initiative Launched by a Coalition of Meharry Medical College, Regeneron Genetics Center, AstraZeneca, Novo Nordisk, and Roche to Improve Health Outcomes for People of African Ancestry
Published: 2023-10-18 (Crawled : 13:00) - globenewswire.com
REGN | News | $906.55 -0.09% -0.08% 370K
|
Health Technology
|
| O: -0.43%
H: 0.04%
C: -0.87%
AZN | News | $71.175 0.46% 0.46% 6.1M
|
Health Technology
|
| O: -3.57%
H: 0.63%
C: -2.34%
initiative change health genomics medical roche
Fortress Biotech Subsidiary Helocyte Announces Option Agreement with City of Hope for Exclusive Worldwide Rights to use a Novel Bispecific CMV/HIV CAR T Cell Therapy (optionally in combination with Triplex) for the Treatment of Adults Living with HIV-1
Published: 2023-10-16 (Crawled : 13:00) - globenewswire.com
AZNCF | News | $140.3 -4.19% 1.5K
|
Health Technology
|
| O: -4.43%
H: 3.6%
C: 3.6%
FBIO | $1.785 -1.38% -1.4% 120K
|
Health Technology
|
| O: 0.34%
H: 4.12%
C: -4.81%
AZN | News | $71.175 0.46% 0.46% 6.1M
|
Health Technology
|
| O: -1.07%
H: 2.0%
C: 1.82%
biotech worldwide hope cell treatment city agreement therapy living
Principal Investigator of Artelo’s CAReS Trial to Participate in Medical Expert Webinar Hosted by H.C. Wainwright to Discuss Current Development Strategies for Cancer-Related Anorexia and Cachexia
Published: 2023-10-04 (Crawled : 13:00) - globenewswire.com
AZNCF | News | $140.3 -4.19% 1.5K
|
Health Technology
|
| O: 0.92%
H: 0.0%
C: 0.0%
AZN | News | $71.175 0.46% 0.46% 6.1M
|
Health Technology
|
| O: 0.42%
H: 0.3%
C: 0.12%
ARTL | News | $1.31 0.0% 5.4K
|
Health Technology
|
| O: 5.84%
H: 0.0%
C: -3.45%
cares medical trial
Fortress Biotech Reports Second Quarter 2023 Financial Results and Recent Corporate Highlights
Published: 2023-08-14 (Crawled : 20:00) - globenewswire.com
DERM | $3.425 -3.25% -3.36% 60K
|
|
| O: -2.75%
H: 4.01%
C: -0.47%
AZNCF | News | $140.3 -4.19% 1.5K
|
Health Technology
|
| O: -1.75%
H: 0.0%
C: -2.23%
MBIO | $0.35 -2.7% -2.77% 120K
|
Health Technology
|
| O: 0.0%
H: 0.07%
C: -5.71%
FBIO | $1.785 -1.38% -1.4% 120K
|
Health Technology
|
| O: -8.92%
H: 0.0%
C: 0.0%
CKPT | $1.44 0.35% 0.35% 180K
|
Health Technology
|
| O: -0.96%
H: 2.42%
C: -2.42%
ATXI | $0.0949 -29.18% -41.2% 12M
|
Health Technology
|
| O: -2.37%
H: 4.0%
C: 0.0%
AZN | News | $71.175 0.46% 0.46% 6.1M
|
Health Technology
|
| O: -1.27%
H: 0.26%
C: -0.61%
biotech financial results
Statkraft and AstraZeneca sign agreement on wind power delivery
Published: 2023-08-09 (Crawled : 07:00) - globenewswire.com
AZN | News | $71.175 0.46% 0.46% 6.1M
|
Health Technology
|
| O: 1.61%
H: 0.95%
C: 0.55%
agreement
Fortress Biotech to Present at the BTIG Virtual Biotechnology Conference 2023
Published: 2023-08-03 (Crawled : 12:20) - globenewswire.com
AZNCF | News | $140.3 -4.19% 1.5K
|
Health Technology
|
| O: -0.08%
H: 0.0%
C: 0.0%
FBIO | $1.785 -1.38% -1.4% 120K
|
Health Technology
|
| O: 1.2%
H: 1.52%
C: -4.99%
AZN | News | $71.175 0.46% 0.46% 6.1M
|
Health Technology
|
| O: -2.88%
H: 1.68%
C: 1.53%
conference biotech
Urica Therapeutics Announces Topline Data from the Phase 1 Clinical Trial Evaluating Dotinurad in Healthy Volunteers in the United States
Published: 2023-06-29 (Crawled : 12:20) - globenewswire.com
AZNCF | News | $140.3 -4.19% 1.5K
|
Health Technology
|
| O: 1.06%
H: 0.72%
C: 0.72%
FBIO | $1.785 -1.38% -1.4% 120K
|
Health Technology
|
| O: 0.0%
H: 7.55%
C: 7.55%
AZN | News | $71.175 0.46% 0.46% 6.1M
|
Health Technology
|
| O: -0.83%
H: 0.89%
C: 0.68%
topline trial therapeutics
Autolus Therapeutics strengthens its Board with the appointment of Dr. Robert Iannone as a Non-Executive Director
Published: 2023-06-20 (Crawled : 11:00) - globenewswire.com
AZNCF | News | $140.3 -4.19% 1.5K
|
Health Technology
|
| O: -0.17%
H: 0.0%
C: 0.0%
JAZZ | $108.38 -1.18% -1.19% 400K
|
Health Technology
|
| O: -0.58%
H: 0.81%
C: 0.08%
AUTL | $4.23 -5.58% -5.91% 2.7M
|
Health Technology
|
| O: 1.73%
H: 4.08%
C: 1.02%
AZN | News | $71.175 0.46% 0.46% 6.1M
|
Health Technology
|
| O: -0.96%
H: 0.17%
C: -0.74%
therapeutics
Helocyte Announces $3.22 Million Grant from the National Cancer Institute for Triplex Phase 2 Clinical Trial Program
Published: 2023-06-15 (Crawled : 12:20) - globenewswire.com
AZNCF | News | $140.3 -4.19% 1.5K
|
Health Technology
|
| O: 0.97%
H: 0.64%
C: 0.64%
FBIO | $1.785 -1.38% -1.4% 120K
|
Health Technology
|
| O: 2.42%
H: 10.78%
C: 7.94%
AZN | News | $71.175 0.46% 0.46% 6.1M
|
Health Technology
|
| O: 1.68%
H: 1.0%
C: 0.84%
cancer grant program trial phase 2
Fortress Biotech Reports First Quarter 2023 Financial Results and Recent Corporate Highlights
Published: 2023-05-15 (Crawled : 20:00) - globenewswire.com
DERM | $3.425 -3.25% -3.36% 60K
|
|
| O: 2.41%
H: 8.42%
C: 1.01%
AZNCF | News | $140.3 -4.19% 1.5K
|
Health Technology
|
| O: 1.17%
H: 0.0%
C: 0.0%
MBIO | $0.35 -2.7% -2.77% 120K
|
Health Technology
|
| O: 0.0%
H: 1.24%
C: -0.23%
FBIO | $1.785 -1.38% -1.4% 120K
|
Health Technology
|
| O: 4.67%
H: 1.34%
C: -10.55%
CKPT | $1.44 0.35% 0.35% 180K
|
Health Technology
|
| O: 1.41%
H: 2.79%
C: -2.79%
ATXI | $0.0949 -29.18% -41.2% 12M
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: 0.0%
AZN | News | $71.175 0.46% 0.46% 6.1M
|
Health Technology
|
| O: 0.44%
H: 0.44%
C: -0.05%
biotech financial results
Sernova Announces Research Collaboration with AstraZeneca to Evaluate Novel Potential Therapeutic Cell Applications
Published: 2023-05-03 (Crawled : 11:00) - globenewswire.com
SEOVF | $0.3252 15.67% 20K
|
Health Technology
|
| O: 16.67%
H: 2.81%
C: -4.73%
AZN | News | $71.175 0.46% 0.46% 6.1M
|
Health Technology
|
| O: 0.75%
H: 0.98%
C: 0.46%
cell research collaboration potential
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.